155 related articles for article (PubMed ID: 5468701)
1. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
Chopra IJ; Solomon DH; Limberg NP
J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
[No Abstract] [Full Text] [Related]
2. [Relation between Basedow's disease and Hashimoto thyroiditis].
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
[No Abstract] [Full Text] [Related]
3. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin levels in thyroid disease.
Glynne A; Thomson JA
Clin Exp Immunol; 1972 Sep; 12(1):71-8. PubMed ID: 4628405
[TBL] [Abstract][Full Text] [Related]
5. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
6. [Human thyroid stimulator (HTS) in thyroid diseases].
Hu ZY
Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
[No Abstract] [Full Text] [Related]
7. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
Mori T; Kriss JP
J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
[No Abstract] [Full Text] [Related]
8. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
9. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
Miyai K; Werner SC
J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
[No Abstract] [Full Text] [Related]
10. The assay of Graves' immunoglobulins: a comparison of different methods.
Hardisty CA; Kendall-Taylor P; Atkinson S; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1983 Jun; 18(6):637-44. PubMed ID: 6136348
[TBL] [Abstract][Full Text] [Related]
11. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?
Brown RS; Jackson IM; Pohl SL; Reichlin S
Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
13. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
Wall JR; Good BF; Forbes IJ; Hetzel BS
Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
Gharib H; Mayberry WE
Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
[No Abstract] [Full Text] [Related]
15. The prediction of relapse after drug treatment of Graves' disease by assay of long acting thyroid stimulator-protector (LATS-P).
Hardisty CA; Hanford L; Munro DS
Clin Endocrinol (Oxf); 1981 May; 14(5):509-17. PubMed ID: 6895487
[TBL] [Abstract][Full Text] [Related]
16. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
Földes J; Takó J; Bános C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
[No Abstract] [Full Text] [Related]
17. [An antibody called LATS].
Letonturier P; Tourneur R
Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
[No Abstract] [Full Text] [Related]
18. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
[No Abstract] [Full Text] [Related]
19. The immunologic basis of Graves's disease.
Volpé R
N Engl J Med; 1972 Aug; 287(9):463-4. PubMed ID: 5068098
[No Abstract] [Full Text] [Related]
20. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
